Company Overview and News

 
TheBaron VII: Tough Market Movement Spells Opportunity

2018-03-28 seekingalpha
The overall portfolio had a weak month due mainly to one company's continued share price weakness, with slight moves downwards in most of the portfolio.
Upvote Downvote

 
43 'Safer' Dividend MoPay All-Cap Stocks Cast Big Yields As Of February 20

2018-02-23 seekingalpha
43 of 161 Monthly Paying (MoPay) Small-Mid-Large (SML) Cap US & Canadian Dividend stocks were tagged "safer" by showing positive annual-returns, and free cash-flow yields greater than their dividend yields.
Upvote Downvote

 
TheBaron Investing: Marijuana Collapses

2018-02-05 seekingalpha
The market has decided to cool on marijuana companies, which is appropriate but frustrating to see an undervalued company decline.
Upvote Downvote

1
The Lean, Mean Income Machine: Volume 1

2018-02-01 seekingalpha
We have been writing for Seeking Alpha for since May 2017. During that time we have covered a lot of our existing long positions and gone in detail occasionally on our macro outlook. We have however skipped a few updates on stocks as there was very little additional information to justify a full article. We have also been asked for more details on our portfolio by our followers. To deal with both these, we decided to give a portfolio overview and explain our methodology.
Upvote Downvote

 
46 Of 147 MoPay Canadian Equities Boast 'Safer' Dividends In January

2018-01-08 seekingalpha
46 of 147 MoPay Canadian (CDN) equities were tagged "safer" because they showed positive annual returns, and free cash flow yields greater than their dividend yield.
Upvote Downvote

 
NorthWest Healthcare Properties: This High-Quality, 7% Yielding REIT Is A Buy

2018-01-07 seekingalpha
NorthWest Healthcare Properties REIT owns medical office and hospital properties in Canada, Brazil, Germany, and Australia.
Upvote Downvote

3
Dividend Sensei Positions For 2018: Something Is Always On Sale

2018-01-03 seekingalpha
My goal is to generate maximum safe yield, with fast dividend growth, and buy stocks at their most undervalued.
Upvote Downvote

 
TheBaron Investing: Happy New Year Update

2017-12-29 seekingalpha
Some major sales and purchases have changed the portfolio weightings, along with one major addition to my current holdings.
Upvote Downvote

 
Today’s Free Reports, Pure Industrial Real Estate Trust, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT

2017-12-13 accesswire
LONDON, UK / ACCESSWIRE / December 13, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the REITs industry: Pure Industrial Real Estate Trust, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT. Access our complimentary up-to-the-minute research reports by becoming an online member now:
Upvote Downvote

 
Research Initiated on Real Estate Stocks, Pure Industrial Real Estate Trust, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT

2017-09-28 accesswire
LONDON, UK / ACCESSWIRE / September 28, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the REITs industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Pure Industrial Real Estate Trust, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT.
Upvote Downvote

 
41 Of 96 MoPay Canadian All-Cap Equities Tagged 'Safer' For August Dividend Returns

2017-08-02 seekingalpha
41 of 96 Monthly Paying (MoPay) Canadian (CDN) Equities were tagged "safer" because they showed positive annual returns, and free cash-flow yield greater than their dividend yield per 7/28/17 data.
Upvote Downvote

 
Daily Coverage on Real Estate Stocks, Pure REIT, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT

2017-07-21 accesswire
LONDON, UK / ACCESSWIRE / July 21, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the REITs industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Pure REIT, Artis REIT, NorthWest Healthcare Properties Real Estate Investment, and Dream Office REIT.
Upvote Downvote

 
Northwest Health Properties: Healthy Returns?

2017-06-27 seekingalpha
The REIT trades at a significant discount to US peers, without the added risk of a health system shakeup.
Upvote Downvote

 
Canadian Real Estate Stocks Under Review: Dream Office REIT, Artis REIT, Pure Industrial Real Estate Trust, and NorthWest Healthcare Properties Real Estate Investment

2017-06-16 accesswire
LONDON, UK / ACCESSWIRE / June 16, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the REITs industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Dream Office REIT, Artis REIT, Pure Industrial Real Estate Trust, and NorthWest Healthcare Properties Real Estate Investment.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...